Literature DB >> 22898252

Acute hyperinsulinemia and reduced plasma free fatty acid levels decrease intramuscular triglyceride synthesis.

Xiao-jun Zhang1, Lijian Wang, Demidmaa Tuvdendorj, Zhanpin Wu, Noe A Rodriguez, David N Herndon, Robert R Wolfe.   

Abstract

OBJECTIVE: To investigate the effect of acute hyperinsulinemia and the resulting decrease in plasma free fatty acid (FFA) concentrations on intramuscular TG synthesis. MATERIALS/
METHODS: U-(13)C(16)-palmitate was infused for 3 h in anesthetized rabbits after overnight food deprivation. Arterial blood and leg muscle were sampled during the tracer infusion. Plasma samples were analyzed for free and TG-bound palmitate enrichments and concentrations. The enrichments and concentrations of palmitoyl-CoA and palmitoyl-carnitine as well as the enrichment of palmitate bound to TG were measured in muscle samples. Fractional synthetic rate (FSR) of intramuscular TG was calculated using the tracer incorporation method. The rabbits were divided into a control group and a hyperinsulinemic euglycemic clamp group. Insulin infusion decreased the rate of appearance of plasma free palmitate (2.00±0.15 vs 0.68±0.20 μmol⋅kg(-1)⋅min(-1); P<.001), decreased plasma FFA concentration (327±61 vs 72±25 nmol/mL; P<.01), decreased the total concentration of intramuscular fatty acyl-CoA plus fatty acyl-carnitine (12.1±1.6 vs 7.0±0.7 nmol/g; P<.05), and decreased intramuscular TG FSR (0.48±0.05 vs 0.21±0.06%/h; P<.01) in comparison with the control group. Intramuscular TG FSR was correlated (P<.01) with both plasma FFA concentrations and intramuscular fatty acyl-CoA concentrations.
CONCLUSIONS: Fatty acid availability is a determinant of intramuscular TG synthesis. Insulin infusion decreases plasma and intramuscular fatty acid availability and thereby decreases TG synthesis.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22898252      PMCID: PMC3518684          DOI: 10.1016/j.metabol.2012.06.002

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  27 in total

1.  Anabolic action of insulin on skin wound protein is augmented by exogenous amino acids.

Authors:  Xiao-Jun Zhang; David L Chinkes; Oivind Irtun; Robert R Wolfe
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-06       Impact factor: 4.310

2.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.

Authors:  P J RANDLE; P B GARLAND; C N HALES; E A NEWSHOLME
Journal:  Lancet       Date:  1963-04-13       Impact factor: 79.321

3.  High triacylglycerol turnover rate in human skeletal muscle.

Authors:  Massimo Sacchetti; Bengt Saltin; David B Olsen; Gerrit van Hall
Journal:  J Physiol       Date:  2004-10-21       Impact factor: 5.182

4.  Intramuscular fatty acid metabolism evaluated with stable isotopic tracers.

Authors:  Z Guo; M D Jensen
Journal:  J Appl Physiol (1985)       Date:  1998-05

5.  Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.

Authors:  G I Shulman; D L Rothman; T Jue; P Stein; R A DeFronzo; R G Shulman
Journal:  N Engl J Med       Date:  1990-01-25       Impact factor: 91.245

6.  The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization.

Authors:  R A DeFronzo; E Jacot; E Jequier; E Maeder; J Wahren; J P Felber
Journal:  Diabetes       Date:  1981-12       Impact factor: 9.461

7.  Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes.

Authors:  B H Goodpaster; J He; S Watkins; D E Kelley
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

8.  Skeletal muscle triglyceride levels are inversely related to insulin action.

Authors:  D A Pan; S Lillioja; A D Kriketos; M R Milner; L A Baur; C Bogardus; A B Jenkins; L H Storlien
Journal:  Diabetes       Date:  1997-06       Impact factor: 9.461

Review 9.  Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.

Authors:  G Boden
Journal:  Diabetes       Date:  1997-01       Impact factor: 9.461

10.  Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration.

Authors:  J A Romijn; E F Coyle; L S Sidossis; A Gastaldelli; J F Horowitz; E Endert; R R Wolfe
Journal:  Am J Physiol       Date:  1993-09
View more
  4 in total

1.  Quantification of muscle triglyceride synthesis rate requires an adjustment for total triglyceride content.

Authors:  Rabia Asghar; Maria Chondronikola; Edgar L Dillon; William J Durham; Craig Porter; Zhanpin Wu; Maria Camacho-Hughes; Clark R Andersen; Heidi Spratt; Elena Volpi; Melinda Sheffield-Moore; Labros Sidossis; Robert R Wolfe; Nicola Abate; Demidmaa R Tuvdendorj
Journal:  J Lipid Res       Date:  2018-08-21       Impact factor: 5.922

2.  Effect of high-fat diet on peripheral blood mononuclear cells and adipose tissue in early stages of diet-induced weight gain.

Authors:  Jake E Lowry; Batbayar Tumurbaatar; Claudia D'Agostino; Erika Main; Traver J Wright; Edgar L Dillon; Tais B Saito; Craig Porter; Clark R Andersen; Douglas L Brining; Janice J Endsley; Melinda Sheffield-Moore; Elena Volpi; Rong Fang; Nicola Abate; Demidmaa R Tuvdendorj
Journal:  Br J Nutr       Date:  2019-12-28       Impact factor: 3.718

3.  Common lipid features of lethal ventricular tarchyarrhythmias (LVTAs) induced by myocardial infarction and myocardial ion channel diseases.

Authors:  Jiayan Wu; Qian Wu; Dian Wang; Jing Kong; Wentao Dai; Xingxing Wang; Xiaojun Yu
Journal:  Sci Rep       Date:  2017-06-26       Impact factor: 4.379

4.  Exploring the potential of black tea based flavonoids against hyperlipidemia related disorders.

Authors:  Ali Imran; Masood Sadiq Butt; Muhammad Sajid Arshad; Muhammad Umair Arshad; Farhan Saeed; Muhammad Sohaib; Rizwan Munir
Journal:  Lipids Health Dis       Date:  2018-03-27       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.